In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem

被引:20
作者
Fukuoka, T
Ohya, S
Utsui, Y
Domon, H
Takenouchi, T
Koga, T
Masuda, N
Kawada, H
Kakuta, M
Kubota, M
Ishii, C
Ishii, C
Sakagawa, E
Harasaki, T
Hirasawa, A
Abe, T
Yasuda, H
Iwata, M
Kuwahara, S
机构
[1] SANKYO CO LTD,BIOL RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN
[2] TOHO UNIV,SCH MED,DEPT MICROBIOL,TOKYO 143,JAPAN
关键词
D O I
10.1128/AAC.41.12.2652
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CS-834 is a novel oral carbapenem antibiotic. This compound is an ester-type prodrug of the active metabolite R-95867. The antibacterial activity of R-95867 was tested against 1,323 clinical isolates of 35 species and was compared with those of oral cephems, i.e., cefteram, cefpodoxime, cefdinir, and cefditoren, and that of a parenteral carbapenem, imipenem. R-95867 exhibited a broad spectrum of activity covering both grampositive and -negative aerobes and anaerobes. Its activity was superior to those of the other compounds tested against most of the bacterial species tested. R-95867 showed potent antibacterial activity against clinically significant pathogens: methicillin-susceptible Staphylococcus aureus including ofloxacin-resistant strains, Streptococcus pneumoniae including penicillin-resistant strains, Clostridium perfringens, Neisseria spp., Moraxella catarrhalis, most members of the family Enterobacteriaceae, and Haemophilus influenzae (MIG at which 90% of strains are inhibited, less than or equal to 0.006 to 0.78 mu g/ml). R-95867 was quite stable to hydrolysis by most of the beta-lactamases tested except the metallo-beta-lactamases from Stenotrophomonas maltophilia and Bacteroides fragilis. R-95867 showed potent bactericidal activity against S. aureus and Escherichia coli. Penicillin-binding proteins 1 and 4 of S. aureus and 1Bs, 2, 3, and 4 of E. coli had high affinities for R-95867. The in vivo efficacy of CS-834 was evaluated in murine systemic infections caused by 16 strains of gram-positive and -negative pathogens. The efficacy of CS-834 was in many cases superior to those of cefteram pivoxil, cefpodoxime proxetil, cefdinir, and cefditoren pivoxil, especially against infections caused by S. aureus, penicillin-resistant S. pneumoniae, E. call, Citrobacter freundii, and Proteus vulgaris. Among the drugs tested, CS-834 showed the highest efficacy against experimental pneumonia in mice caused by penicillin-resistant S. pneumoniae.
引用
收藏
页码:2652 / 2663
页数:12
相关论文
共 30 条
[1]   BETA-LACTAMASE PRODUCED BY A HIGHLY BETA-LACTAM-RESISTANT STRAIN OF BACTEROIDES-FRAGILIS - AN OBSTACLE TO THE CHEMOTHERAPY OF EXPERIMENTAL MIXED INFECTIONS [J].
AJIKI, Y ;
KOGA, T ;
OHYA, S ;
TAKENOUCHI, T ;
YASUDA, H ;
WATANABE, K ;
UENO, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (04) :537-546
[2]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[3]   The method of probits [J].
Bliss, C. I. .
SCIENCE, 1934, 79 (2037) :38-39
[4]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[5]   INFECTIONS DUE TO PENICILLIN-RESISTANT PNEUMOCOCCI - CLINICAL, EPIDEMIOLOGIC, AND MICROBIOLOGIC FEATURES [J].
CAPUTO, GM ;
APPELBAUM, PC ;
LIU, HH .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (11) :1301-1310
[6]  
*COMM REV MIC DET, 1981, CHEMOTHERAPY-TOKYO, V29, P76
[7]  
CURTIS NAC, 1981, FEMS MICROBIOL LETT, V10, P227
[8]  
CURTIS NAC, 1980, FEMS MICROBIOL LETT, V9, P263
[9]   PURIFICATION AND PROPERTIES OF BETA-LACTAMASE FROM PROTEUS-MORGANII [J].
FUJIIKURIYAMA, Y ;
YAMAMOTO, M ;
SUGAWARA, S .
JOURNAL OF BACTERIOLOGY, 1977, 131 (03) :726-734
[10]   POSSIBLE PHYSIOLOGICAL FUNCTIONS OF PENICILLIN-BINDING PROTEINS IN STAPHYLOCOCCUS-AUREUS [J].
GEORGOPAPADAKOU, NH ;
DIX, BA ;
MAURIZ, YR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) :333-336